MARK MUNGER
Professor Emeritus
Pharmacotherapy
- Professor EmeritusPharmacotherapy
RESEARCH INTERESTS
- Repurposing drugs to address major public health concerns, unique value propositions and differentiation, with the potential for commercial product value
- Conducting research on the expanding use of medical cannabis in the State of Utah
- Improving medication safety across the United States using an artificial intelligence system to identify pharmacokinetic, dynamic, and genomic interactions allowing actionable changes to patient drug profiles
GRANTS
- EXTERNAL GRANT OR CONTRACTASSESSMENT OF RILUZOLE TO REDUCE PAROXYSMAL EPISODES OF ATRIAL FIBRILLATION (THE SOLUTION STUDY)30 Dec 2021 - 30 Jun 2024
- EXTERNAL GRANT OR CONTRACTMUNGER - ALSAM WITH DENVERUNIVERSITY OF COLORADO AT DENV1 Jan 2019 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTCOMMUNITY PHARMACY SERVICESSKAGGS INSTITUTE FOR RESEARCH1 Jan 2015 - 31 Dec 2017
- EXTERNAL GRANT OR CONTRACTPRIMARY CARE IN PHARMACIESSKAGGS FOUNDATION FOR RESEARCH11 Dec 2014 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTSTATE INNOVATION MODEL GRANTUTAH DEPARTMENT OF HEALTH4 Jan 2013 - 31 Dec 2013
- EXTERNAL GRANT OR CONTRACTBARD EVAL SALINE SOLUTIONBARD ACCESS SYSTEMS7 Sep 2012 - 10 May 2012
- EXTERNAL GRANT OR CONTRACTPHARMACY LISENSURE MP12023STATE OF UTAH7 Jan 2012 - 31 Dec 2013
- EXTERNAL GRANT OR CONTRACTCLINICAL STUDY CVEA489US501NOVARTIS PHARMACEUTICALS CORP8 Jan 2009 - 31 Dec 2010
- EXTERNAL GRANT OR CONTRACTRIBOSE EFFECTS ON CARDIAC PTSBIOENERGY INC4 Oct 2006 - 31 Dec 2007
- EXTERNAL GRANT OR CONTRACTAGELESS TRIALNOVARTIS PHARMACEUTICALS CORP2 Mar 2006 - 2 Aug 2008
- EXTERNAL GRANT OR CONTRACTCSPP100A2327NOVARTIS PHARMACEUTICALS CORP12 Dec 2005 - 31 Dec 2006
- EXTERNAL GRANT OR CONTRACTSAFETY & EFFICACY OF ALISKIRENNOVARTIS PHARMACEUTICALS CORP4 Jan 2005 - 12 Jan 2006
- EXTERNAL GRANT OR CONTRACTALISKIREN/VALSARTANNOVARTIS PHARM CORP2 Dec 2004 - 2 Jan 2006
- EXTERNAL GRANT OR CONTRACTALISKREN HYPERTENSION STUDYNOVARTIS PHARM CO5 Dec 2003 - 31 Dec 2004
- EXTERNAL GRANT OR CONTRACTRIBOSE/ASSESS LIFE QUALITYBIOENERGY INC11 Jan 2003 - 31 Dec 2004
- EXTERNAL GRANT OR CONTRACTPEAK EXERCISE TOLERANCEAMER COLLEGE OF CLINICAL PHARM7 Jan 2003 - 31 Dec 2004
- EXTERNAL GRANT OR CONTRACTACCOMPLISHNOVARTIS PHARMACEUTICALS CORP6 Jan 2003 - 6 Jan 2009
- EXTERNAL GRANT OR CONTRACTNATEGLINIDE CALSARTAN IGTNOVARTIS PHARMACEUTICALS CORP12 Jan 2001 - 9 Jan 2010
- EXTERNAL GRANT OR CONTRACTVALSARTAN/ENDOTHELIAL FUNCTIONNOVARTIS PHARM CO12 Jan 2001 - 31 Dec 2004
- EXTERNAL GRANT OR CONTRACTCANDESARTAN CILEXETIL+LISINOPRASTRA-ZENECA PHARMACEUTICAL CO6 Jan 2001 - 31 Dec 2002
- EXTERNAL GRANT OR CONTRACTOMAPATRILAT VS ENALAPRIL (OCTABRISTOL-MEYERS SQUIBB (PPD DEV10 Jan 2000 - 1 Jan 2002
- FELLOWSHIP OR RESIDENCYAFPE FELLOW CHEANGAMER FNDN FOR PHARM ED9 Jan 2000 - 31 Dec 2001
- EXTERNAL GRANT OR CONTRACTBMS207940/HEART FAILUREBRISTOL MEYERS SQUIBB6 Jan 2000 - 31 Dec 2001
- EXTERNAL GRANT OR CONTRACTOPERA STUDYBRISTOL-MEYERS SQUIBB1 Jan 2000 - 31 Dec 2005
- EXTERNAL GRANT OR CONTRACTSIMVASTATIN TISSUE FACTOR EXPMERCK & COMPANY INC1 Jan 2000 - 31 Dec 2007